Baker Tilly Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,896
| Closed | -$643K | – | 580 |
|
|
2023
Q1 | $643K | Sell |
5,896
-5,159
| -47% | -$563K | 0.07% | 277 |
|
|
2022
Q4 | $1.26M | Sell |
11,055
-4,405
| -28% | -$501K | 0.15% | 155 |
|
|
2022
Q3 | $957K | Sell |
15,460
-821
| -5% | -$50.8K | 0.13% | 173 |
|
|
2022
Q2 | $1.3M | Buy |
16,281
+2,048
| +14% | +$163K | 0.17% | 129 |
|
|
2022
Q1 | $1.5M | Sell |
14,233
-33
| -0.2% | -$3.47K | 0.17% | 128 |
|
|
2021
Q4 | $1.54M | Buy |
14,266
+693
| +5% | +$74.7K | 0.17% | 129 |
|
|
2021
Q3 | $1.49M | Buy |
13,573
+6,183
| +84% | +$677K | 0.2% | 99 |
|
|
2021
Q2 | $692K | Buy |
7,390
+1,036
| +16% | +$97K | 0.11% | 204 |
|
|
2021
Q1 | $585K | Buy |
6,354
+780
| +14% | +$71.8K | 0.12% | 208 |
|
|
2020
Q4 | $408K | Buy |
+5,574
| New | +$408K | 0.13% | 177 |
|